Dimensional Fund Advisors LP Boosts Holdings in HealthEquity, Inc. $HQY

Key Points

• Dimensional Fund Advisors LP increased its stake in HealthEquity by 2.5% to 1,559,008 shares (about 1.81% ownership) valued at roughly $147.75 million at quarter-end.
• Analysts rate HQY a “Moderate Buy” with an average price target of $112, though opinions vary from a sell by Goldman Sachs ($89 target) to upgraded/overweight views and higher targets from firms like JPMorgan and KeyCorp.
• Institutional ownership is very high at 99.55% while insiders hold 1.50%; two executive VPs recently sold shares (Elimelech Rosner sold 10,959 shares and Delano Ladd sold 1,500 shares), slightly reducing insider stakes.

Dimensional Fund Advisors LP increased its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 2.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,559,008 shares of the company's stock after purchasing an additional 38,154 shares during the period. Dimensional Fund Advisors LP owned approximately 1.81% of HealthEquity worth $147,751,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Sivia Capital Partners LLC purchased a new position in HealthEquity in the second quarter worth about $306,000. Campbell & CO Investment Adviser LLC grew its holdings in shares of HealthEquity by 329.0% during the second quarter. Campbell & CO Investment Adviser LLC now owns 16,918 shares of the company's stock valued at $1,772,000 after buying an additional 12,974 shares during the last quarter. Allworth Financial LP grew its holdings in shares of HealthEquity by 283.1% during the second quarter. Allworth Financial LP now owns 747 shares of the company's stock valued at $78,000 after buying an additional 552 shares during the last quarter. SBI Securities Co. Ltd. increased its position in shares of HealthEquity by 25,100.0% during the second quarter. SBI Securities Co. Ltd. now owns 756 shares of the company's stock valued at $79,000 after acquiring an additional 753 shares in the last quarter. Finally, Beck Bode LLC increased its position in shares of HealthEquity by 7.4% during the second quarter. Beck Bode LLC now owns 5,771 shares of the company's stock valued at $605,000 after acquiring an additional 396 shares in the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity Trading Down 1.9%

NASDAQ:HQY opened at $78.50 on Wednesday. The company has a current ratio of 4.13, a quick ratio of 4.13 and a debt-to-equity ratio of 0.46. HealthEquity, Inc. has a 12 month low of $72.76 and a 12 month high of $116.65. The company has a market cap of $6.71 billion, a PE ratio of 36.01, a price-to-earnings-growth ratio of 1.00 and a beta of 0.26. The company has a 50 day simple moving average of $82.74 and a two-hundred day simple moving average of $90.63.

Wall Street Analysts Forecast Growth

HQY has been the topic of several analyst reports. Jefferies Financial Group set a $108.00 price objective on HealthEquity in a research report on Thursday, February 19th. Barrington Research restated an "outperform" rating and issued a $125.00 price target on shares of HealthEquity in a research note on Thursday, December 4th. The Goldman Sachs Group downgraded HealthEquity from a "neutral" rating to a "sell" rating and set a $89.00 price target on the stock. in a report on Friday, January 9th. KeyCorp increased their price objective on HealthEquity from $120.00 to $125.00 and gave the company an "overweight" rating in a research report on Thursday, January 8th. Finally, JPMorgan Chase & Co. lifted their price objective on HealthEquity from $126.00 to $129.00 and gave the stock an "overweight" rating in a report on Thursday, December 4th. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $112.00.

Insider Buying and Selling at HealthEquity

In related news, EVP Elimelech Rosner sold 10,959 shares of HealthEquity stock in a transaction on Thursday, December 18th. The stock was sold at an average price of $95.45, for a total value of $1,046,036.55. Following the completion of the sale, the executive vice president owned 45,742 shares of the company's stock, valued at $4,366,073.90. The trade was a 19.33% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Delano Ladd sold 1,500 shares of the company's stock in a transaction on Friday, December 19th. The shares were sold at an average price of $94.72, for a total value of $142,080.00. Following the sale, the executive vice president owned 73,979 shares of the company's stock, valued at approximately $7,007,290.88. This trade represents a 1.99% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 1.50% of the company's stock.

HealthEquity Profile

HealthEquity, Inc NASDAQ: HQY is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.